Business Context and Reporting Period
Company: Arcadia Biosciences, Inc. (Nasdaq: RKDA)
Filing Date: December 4, 2024
Event: Entry into a Material Definitive Agreement (Securities Exchange Agreement) with Roosevelt Resources, LP.
Transaction Type: All-stock merger resulting in a change of control and corporate name.
Key Financial Metrics
This filing is a Current Report on Form 8-K and does not contain audited financial statements, revenue, profit, cash flow, or margin data for either Arcadia or Roosevelt. The filing text does not provide clear values for current liquidity, debt levels, or operating metrics.
Transaction Economics:
- Ownership Structure: Post-closing, current Roosevelt equity owners are expected to own approximately 90% of the combined company, while existing Arcadia stockholders will own approximately 10%.
- Termination Fees:
- If Arcadia terminates due to Roosevelt's intentional fraud or breach: Up to $750,000 reimbursement.
- If Roosevelt terminates due to Arcadia's intentional fraud or breach: Up to $750,000 reimbursement.
- If Arcadia enters an Alternative Acquisition Agreement: $500,000 reimbursement to Roosevelt.
Material Changes and Transaction Details
The primary material change is the proposed combination of Arcadia Biosciences, Inc. and Roosevelt Resources, LP.
- Target Profile: Roosevelt is a privately-held exploration and production company based in Dallas, Texas. Its primary asset is a Carbon Capture Utilization and Storage (CCUS) oil and natural gas project on the Northwest Shelf of the Texas Permian Basin, spanning 16,208 contiguous acres (13,892 net).
- Corporate Name Change: Arcadia will change its name to "Roosevelt Resources, Inc." upon closing.
- Management Changes: Upon closing, Roosevelt's management team is expected to lead the combined company:
- Elliot "Tony" Roosevelt, Jr. (CEO)
- Jimmy C. Hawkins (President)
- Jerrel Branson (CFO)
- Paul Buckner (Chief Legal Officer)
- Board Composition: The new board is expected to include three current Roosevelt directors and two additional independent directors.
Guidance, Outlook, and Risks
Timeline and Conditions:
- Expected Closing: First quarter of 2025 or thereafter, subject to conditions.
- Outside Date: May 15, 2025 (subject to extension).
- Conditions Precedent: Approval by Arcadia stockholders and Roosevelt partners; effectiveness of SEC Form S-4 registration statement; Nasdaq listing approval; and absence of prohibitory laws.
Management Commentary: The transaction is intended to pivot the company toward oil and gas development with a focus on CCUS technology. A special meeting of Arcadia stockholders will be held to vote on the issuance of shares, a new long-term incentive plan, and potential reverse stock split authority.
Risks and Contingencies:
- Transaction Failure: Risks include failure to obtain stockholder approval, regulatory prohibition, or termination by either party.
- Operational Risks: Future performance depends on oil and gas prices, reserve estimates, development success, and regulatory changes regarding environmental matters and taxation.
- Integration Risks: Potential disruption to business operations and diversion of management time.
Investor Verification Checklist
- Verify the final ownership percentage split (90/10) in the definitive proxy statement/prospectus (Form S-4).
- Confirm the specific terms of the reverse stock split, if authorized by the board.
- Review the detailed financial statements and reserve estimates for Roosevelt Resources in the upcoming Form S-4.
- Monitor the status of the SEC Form S-4 registration statement effectiveness.
- Attend the special stockholder meeting to vote on the transaction and related proposals.